Interim Results of Johnson & Johnson Single-Dose COVID-19 Vaccine Shows 90% Efficacy
January 15th 2021The single dose investigational vaccine being developed by the Janssen Pharmaceutical Companies of Johnson & Johnson is a recombinant, replication-incompetent adenovirus serotype 26 vector encoding a stabilized SARS-CoV-2 spike protein.
Read More
Study: Increasing Exercise During First Trimester May Reduce Gestational Diabetes Risk
January 14th 2021The analysis found that at least 38 minutes of moderate intensity exercise each day was associated with the lower risk, which is a little more than the current recommendations of at least 30 minutes a day, 5 days a week.
Read More
Study: Higher Vaccine Rates Associated with Indicative Language by Provider, More Efficient
January 14th 2021The new research shows that adolescents are 9 times more likely to receive a vaccine when providers introduce the topic to parents with a simple statement such as “your child is due for vaccines today,” as it results in a shorter vaccine discussion.
Read More
Study: Initial Severity of COVID-19 Not Associated with Later Respiratory Complications
January 14th 2021Liam Townsend, MD, and his co-authors looked at a number of measures of recovery for 153 patients who were followed in an outpatient clinic a median of 75 days after their COVID-19 diagnoses.
Read More
Low Immunity Linked to Poor Outcomes in Patients with HIV, COVID-19
January 13th 2021As patients with HIV are living longer, they are also being diagnosed with chronic conditions that have become increasingly common in recent decades, putting them at higher risk of COVID-19 hospitalization and death.
Read More
Researchers from the University of Texas MD Anderson Cancer Center found that men with localized prostate cancer who reported a baseline dietary pattern that more closely follows the key principles of a Mediterranean-style diet fared better over the course of their disease.
Read More